Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

Discover the best large-cap stocks for value and dividend safety using YCharts' Value Score and Ben Graham Formula. Click for ...

Passive income investors like me are always on the lookout for different ways to generate extra income. If you can make your money work for you, why not? I believe investing should not only generate ...

The world of investing involves uncertainty, volatility, and ever-changing macroeconomic conditions. In such scenarios, ...

Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full ...

Pfizer is conducting a critical Phase 3 clinical trial for the drug elranatamab, targeting relapsed or refractory multiple myeloma. The trial compares elranatamab alone and combined with daratumumab ...